Equities research analysts at William Blair issued their Q1 2025 earnings per share estimates for MiNK Therapeutics in a ...

Q4 2024 Earnings Call Transcript March 18, 2025 MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

Vectors for Infection Risk in the United States Act (Mink VIRUS Act), bipartisan legislation endorsed by the Animal Welfare ...

For the first time in five years, since 2019, the Southwest Virginia Wildlife Center is caring for an American Mink. The mink ...

MiNK Therapeutics (NASDAQ:INKT – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a report issued on Tuesday,Benzinga reports. They currently have a ...

Patsy Takemoto Mink shattered barriers as the first Asian American woman in Congress and a champion of Title IX. Now, her ...

MiNK advanced its mission to bring off-the-shelf iNKT cell therapies to patients fighting hard-to-treat cancers and severe ...

SPRINGFIELD, Ill. (WAND) — A bill filed by a State House Democrat would add regulations on an unregulated minx fur trade in ...

We ended the year with a cash balance of $4.6 million. Cash used in operations for the three and twelve months ended December 31, 2024, was $1.7 million, and $9.6 million, respectively, compared to $3 ...

MiNK Therapeutics NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the ...